TheEdgeResearch
Home / Stocks / NEO

NeoGenomics, Inc. (NEO)

NASDAQ Healthcare Medical - Diagnostics & Research
$16.53 ▼ -0.60%
Market Cap
$424.7M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.73
52-Wk Range
5.78-16.92
CEO
Anthony Zook
Country
US
Currency
USD

NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines normal and abnormal chromosomes in relation to disease…

Open full interactive analysis & DCF →